Why You Shouldn’t Mix Alcohol with Metronidazole Pills

Many times we are told by our doctors not to combine certain medicines with other drugs and chemicals due to its potential side effects and drug interactions. Before you are prescribed with certain medicines by your doctor, you should be well aware of the precautions as well as how the medications will function so that you will know what to expect. Generally this is part of the patient safety rules. That is why you will find a leaflet packed together with the medicines you have bought so you can have something to glance on during your treatment. Leaflets contain the general instructions, precautions, the general dos and don’ts, as well as a brief list of drugs or chemical that you should never combine with your medication.

Metronidazole pills are antibacterial drugs with its sole purpose to kill and eliminate infections caused by various types of bacteria and parasites. Most of these infections can occur in the digestive tract, genital area, lungs, and other internal organs. With metronidazole pills it is easier to eliminate such body intruders by simply killing the pathogens and parasites and prevent them from coming back.

Although Metronidazole pills are very powerful and beneficial antibiotic, take note that it is still a drug that might have some drawbacks especially when taken together with other chemicals and drugs. That is why you need to discuss with your doctor about your treatment prior of taking Metronidazole pills. Among the most prohibited chemicals that you should never ingest with metronidazole is alcohol. So what makes Metronidazole pills and alcohol a dangerous combo? Read more…

Relistor may weaken the GI wall

When to beware

As all meds do, mythylnaltrexone bromide (Relistor) has its share of possible side effects, the most common being dizziness, flatulence, mild diarrhea, nausea, stomach pain, vomiting, and hyperhidrosis. Severe reactions include a serious case of any already mentioned, or allergic reactions.

Today, Health Canada and Wyeth Canada added a new possible adverse reaction to the list: a heightened risk of gastrointestinal perforation, especially in those with GI cancers and other conditions that could weaken the gastrointestinal wall.

When Relistor came onto the scene – it was approved by Health Canada on March 28, 2008 – it relieved opioid-induced constipation in palliative-care patients with incurable cancers, end-stage COPD from emphysema, heart failure, Alzheimer’s disease, and so on, when other laxative therapies could not – in under 30 minutes. Administered by subcutaneous injection, it blocks opioids from entering cells, allowing bowels to revert to normal function, while not interfering with the opioid’s ability to relieve pain.

The current warning advises discontinuing Relistor and seeking professional help if severe, persistent symptoms like abdominal pain intensified by movement, nausea and vomiting -- possibly accompanied by fever and chills – worsen, as these can be signs of GI perforation.

It makes one wonder, though, if the original studies on this drug should have lasted a wee bit longer than four months.
Milena Katz

2 comments:

said...

All meds have side effects. SO you offer don't take mythylnaltrexone bromide?

said...

Such a wonderful post. keep it up and thanks for sharing.